Fig. 3. Metabolic analysis of iCDM-34 and anti-HBV activity of iCDM-34 in human hepatocyte-chimeric mice.
A Metabolic analysis of iCDM-17, iCDM-34, and CDM-3008 in human, rat, and mouse liver microsomal fractions. B Metabolic analysis of iCDM-34 in vivo. iCDM-34 was injected into human hepatocyte-chimeric mouse, and then iCDM-34 concentration in the blood was measured at 5, 30, 60, 240, 480 min after the injection (n = 1). C iCDM-34 (1 mg/kg, i.v.) was injected with or without ETV (0.03 mg/kg, p.o.) once a day. After 21 days of injections, DNA was purified from the liver, and then HBV DNA (D, E) levels with or without ETV were measured by qPCR. The data are presented as means ± SD (n = 4). * p < 0.05 in one-sided student’s t test.
